Member of the European Molecular Biology Organization (EMBO)
Pierre Boulanger spends much of his time researching Molecular biology, Recombinant DNA, Virus, Virology and Capsid. His work deals with themes such as Biopanning, In vitro, Gene expression, Recombinant virus and Receptor, which intersect with Molecular biology. His research in Recombinant DNA intersects with topics in Chromatography, Serotype and Genetic enhancement.
The various areas that he examines in his Virus study include Immunoprecipitation, Lysis and Point mutation. In his study, Epitope, Cytotoxic T cell and Human leukocyte antigen is inextricably linked to Immune system, which falls within the broad field of Virology. His work in Capsid covers topics such as Antibody which are related to areas like Viral protein.
The scientist’s investigation covers issues in Molecular biology, Virology, Capsid, Recombinant DNA and Cell biology. His Molecular biology study integrates concerns from other disciplines, such as Mutant, Receptor, Virus, Transduction and Adenoviridae. His study in the field of Integrin is also linked to topics like Fiber.
Pierre Boulanger combines subjects such as Budding, Cleavage, Gene, Genetic enhancement and Antibody with his study of Virology. His Capsid study combines topics from a wide range of disciplines, such as Plasma protein binding, Immune system, Antigen, Peptide sequence and Peptide. His research in the fields of Recombinant virus overlaps with other disciplines such as Sf9.
Pierre Boulanger focuses on Cell biology, Molecular biology, Capsid, Virology and Intracellular. The study incorporates disciplines such as Small hairpin RNA, Apoptosis, Innate immune system and Downregulation and upregulation in addition to Cell biology. His work carried out in the field of Molecular biology brings together such families of science as Plasma protein binding, Enzyme, Luciferase, Transduction and Cytotoxicity.
His Capsid research is multidisciplinary, relying on both Complementary DNA, Vector and Ankyrin. His Virology research includes themes of Autographa californica, Cell killing and Cellular pathology. His Intracellular study deals with Cell intersecting with Membrane glycoproteins, Receptor, Chinese hamster ovary cell, Virus maturation and Cleavage.
Pierre Boulanger mostly deals with Cell biology, Virology, Capsid, Plasma protein binding and p38 mitogen-activated protein kinases. The concepts of his Cell biology study are interwoven with issues in HEK 293 cells, A549 cell, Chloride channel activity and Immunology. The various areas that Pierre Boulanger examines in his Virology study include Protein structure, Vector and Viral vector.
His Capsid research is multidisciplinary, relying on both Complementary DNA, Genetic enhancement and Cell membrane. His studies deal with areas such as Recombinant DNA, Cellular immunity, Ankyrin, Peptide sequence and Viral replication as well as Plasma protein binding. P38 mitogen-activated protein kinases is intertwined with Innate immune system, Downregulation and upregulation, Small hairpin RNA, Apoptosis and Inflammation in his study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Adenovirus type 5 fiber knob binds to MHC class I α2 domain at the surface of human epithelial and B lymphoblastoid cells
Saw See Hong;Lucie Karayan;Jeannette Tournier;David T. Curiel.
The EMBO Journal (1997)
Human adenovirus-host cell interactions: comparative study with members of subgroups B and C.
C Defer;M T Belin;M L Caillet-Boudin;P Boulanger.
Journal of Virology (1990)
Immune Response to Recombinant Capsid Proteins of Adenovirus in Humans: Antifiber and Anti-Penton Base Antibodies Have a Synergistic Effect on Neutralizing Activity
Hanne Gahéry-Ségard;Françoise Farace;Dominique Godfrin;Jesintha Gaston.
Journal of Virology (1998)
Organization of Immature Human Immunodeficiency Virus Type 1
Thomas Wilk;Ingolf Gross;Brent E. Gowen;Twan Rutten.
Journal of Virology (2001)
Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response
Valérie Molinier-Frenkel;Renée Lengagne;Florence Gaden;Saw-See Hong.
Journal of Virology (2002)
Genetic retargeting of adenovirus: novel strategy employing "deknobbing" of the fiber.
Maria K. Magnusson;Saw See Hong;Pierre Boulanger;Leif Lindholm.
Journal of Virology (2001)
Immune Response to Recombinant Adenovirus in Humans: Capsid Components from Viral Input Are Targets for Vector-Specific Cytotoxic T Lymphocytes
Valérie Molinier-Frenkel;Hanne Gahery-Segard;Majid Mehtali;Christophe Le Boulaire.
Journal of Virology (2000)
A versatile and scalable two-step ion-exchange chromatography process for the purification of recombinant adeno-associated virus serotypes-2 and -5.
Nicole Brument;Robert Morenweiser;Véronique Blouin;Estelle Toublanc.
Molecular Therapy (2002)
Deletion analysis of functional domains in baculovirus-expressed adenovirus type 2 fiber.
Armelle Novelli;Pierre A. Boulanger.
Virology (1991)
Adenovirus type 2 assembly analyzed by reversible cross-linking of labile intermediates.
J C D'Halluin;G R Martin;G Torpier;P A Boulanger.
Journal of Virology (1978)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Scripps Research Institute
Grenoble Alpes University
Grenoble Alpes University
Leiden University Medical Center
KTH Royal Institute of Technology
Université Paris Cité
University of Iowa
University of Poitiers
KTH Royal Institute of Technology
Inserm
Carnegie Mellon University
University of Illinois at Urbana-Champaign
The University of Texas at Dallas
University of Veterinary Medicine Vienna
University of Sassari
University of Tübingen
National Central University
Emory University
Shimane University
University of Copenhagen
University of Michigan–Ann Arbor
Duke University
Utrecht University
University of Mannheim
University of Illinois at Urbana-Champaign
National Academies of Sciences, Engineering, and Medicine